Cleveland Clinic and The Hebrew University of Jerusalem Join to Develop Global Center for Transformative Nanomedicine

An innovative partnership between Cleveland Clinic and The Hebrew University of Jerusalem to create a global Center for Transformative Nanomedicine has the potential to impact patients around the world by taking a bold new approach to the delivery of novel therapies and treatments.

By harnessing the power of nanoscience and nanotechnology, this collaboration will blaze new research paths, especially in the areas of cardiovascular disease, neurological disease and cancer, by creating novel drug delivery systems and unique medical technologies with lifesaving potential.

Cleveland Clinic is a leader in laboratory-based, translational and clinical research, while The Hebrew University of Jerusalem is top-ranked in biotechnology, nanotechnology, molecular modeling and drug development. By combining resources and sharing scientific knowledge, the Center for Transformative Nanomedicine will translate scientific discoveries into practical applications to prevent, diagnose and treat illness.